We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNRG icon
4201
PrimeEnergy Resources
PNRG
$323M
$2.88K ﹤0.01%
25
+16
+178% +$1.88K
VNCE icon
4202
Vince Holding Corp
VNCE
$77.6M
$2.85K ﹤0.01%
150
+3
+2% +$41
VNTR
4203
DELISTED
Venator Materials PLC
VNTR
$2.83K ﹤0.01%
1,161
+490
+73% +$1.56K
CKPT
4204
DELISTED
Checkpoint Therapeutics
CKPT
$2.79K ﹤0.01%
112
+106
+1,767% +$2.91K
LRMR icon
4205
Larimar Therapeutics
LRMR
$454M
$2.75K ﹤0.01%
310
SPFI icon
4206
South Plains Financial
SPFI
$858M
$2.71K ﹤0.01%
166
+2
+1% +$34
TRCB
4207
DELISTED
Two River Bancorp
TRCB
$2.66K ﹤0.01%
128
NVTR
4208
DELISTED
Nuvectra Corporation Common Stock
NVTR
$2.64K ﹤0.01%
1,941
NVGS icon
4209
Navigator Holdings
NVGS
$1.26B
$2.64K ﹤0.01%
247
-270
-52% -$2.69K
EARN
4210
Ellington Residential Mortgage REIT
EARN
$163M
$2.6K ﹤0.01%
247
EQ icon
4211
Equillium
EQ
$138M
$2.59K ﹤0.01%
682
BRID icon
4212
Bridgford Foods
BRID
$57.4M
$2.56K ﹤0.01%
85
+81
+2,025% +$2.81K
NMTR
4213
DELISTED
9 Meters Biopharma
NMTR
$2.55K ﹤0.01%
119
ROAN
4214
DELISTED
Roan Resources, Inc.
ROAN
$2.45K ﹤0.01%
1,994
-261
-12% -$340
LBY
4215
DELISTED
Libbey, Inc.
LBY
$2.45K ﹤0.01%
732
-493
-40% -$964
LLEX
4216
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$2.3K ﹤0.01%
6,902
FBRX icon
4217
Forte Biosciences
FBRX
$1.57B
$2.24K ﹤0.01%
9
+3
+50% +$4.55K
IMDX
4218
Insight Molecular Diagnostics
IMDX
$147M
$2.22K ﹤0.01%
53
+49
+1,225% +$1.93K
VRDN icon
4219
Viridian Therapeutics
VRDN
$2.59B
$2.21K ﹤0.01%
201
KEG
4220
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$2.2K ﹤0.01%
1,479
BBCP icon
4221
Concrete Pumping Holdings
BBCP
$479M
$2.15K ﹤0.01%
541
+5
+0.9% +$21
USWS
4222
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$2.14K ﹤0.01%
47
+35
+292% +$2.3K
BTAI icon
4223
BioXcel Therapeutics
BTAI
$32.7M
$2.1K ﹤0.01%
19
+18
+1,800% +$2.84K
LYTS icon
4224
LSI Industries
LYTS
$890M
$2.06K ﹤0.01%
395
CTRC
4225
DELISTED
Centric Brands Inc. Common Stock
CTRC
$2.05K ﹤0.01%
816
+773
+1,798% +$2.16K

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.